Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1371)
ARTG (121)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2025 (2)
2024 (1185)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (5)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (17)
2012 (9)
2011 (12)
2010 (3)
2009 (7)

Results for "[search-keyword]"

Search

Sponsor content

1525 result(s) found, displaying 1361 to 1370

OceanEarth SUPER KRILL ULTRA - 500 mg (Medis Pharma Pty Ltd)

10 January 2020

Listed medicine compliance report

Medicine continues to be permitted for supply (View full entry for advice on the safety of using this medicine.)
GN-AMOXYCILLIN amoxicillin trihydrate 250mg hard capsules blister pack Cancelled under Section 30(1)(c) of the Act

25 November 2019

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
GN-AMOXYCILLIN amoxicillin trihydrate 500mg hard capsules blister pack Cancelled under Section 30(1)(c) of the Act

25 November 2019

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
AMOXYCILLIN/CLAVULANIC ACID ACTAVIS 875/125 amoxicillin 875 mg (as trihydrate) and clavulanic acid 125 mg (as potassium clavulanate) tablet strip pack Cancelled under Section 30(1)(c) of the Act

19 November 2019

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
AMOXYCILLIN/CLAVULANIC ACID ACTAVIS 500/125 amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium clavulanate) tablet strip pack Cancelled under Section 30(1)(c) of the Act

19 November 2019

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
TEVA-EVEROLIMUS everolimus 2.5 mg tablet blister pack (277301)

20 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TEVA-EVEROLIMUS everolimus 2.5 mg tablet blister pack.
TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack (277302)

20 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TEVA-EVEROLIMUS everolimus 5 mg tablet blister pack.
TEVA-EVEROLIMUS everolimus 10 mg tablet blister pack (277304)

20 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TEVA-EVEROLIMUS everolimus 10 mg tablet blister pack.
AZITHROMYCIN AN azithromycin (as monohydrate) 500mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
INDAHEXAL Indapamide hemihydrate 2.5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2019

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 133
Page 134
Page 135
Page 136
Current page 137
Page 138
Page 139
Page 140
Page 141
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.